Curran, B.P., Murray, H.J. & O'Connor, J.J. (2003) A role for c-Jun N-terminal
kinase in the inhibition of long-term potentiation by interleukin-1beta and
long-term depression in the rat dentate gyrus in vitro. Neuroscience, 118,
347–357.
van Dam, H., Wilhelm, D., Herr, I., Steffen, A., Herrlich, P. & Angel, P. (1995)
ATF-2 is preferentially activated by stress-activated protein kinases to
mediate c-jun induction in response to genotoxic agents. EMBO J., 14,
1798–1811.
Guan, Z., Kim, J.H., Lomvardas, S., Holick, K., Xu, S., Kandel, E.R. &
Schwartz, J.H. (2003) p38 MAP kinase mediates both short-term and longterm synaptic depression in aplysia. J. Neurosci., 23, 7317–7325.
Huber, K.M., Kayser, M.S. & Bear, M.F. (2000) Role for rapid dendritic protein
synthesis in hippocampal mGluR-dependent long-term depression. Science,
288, 1254–1257.
Jacobs-Helber, S.M. & Sawyer, S.T. (2004) Jun N-terminal kinase promotes
proliferation of immature erythroid cells and erythropoietin-dependent cell
lines. Blood, 104, 696–703.
Kang, Y.J., Jeon, E.S., Song, H.Y., Woo, J.S., Jung, J.S., Kim, Y.K. & Kim, J.H.
(2005) Role of c-Jun N-terminal kinase in the PDGF-induced proliferation
and migration of human adipose tissue-derived mesenchymal stem cells.
J. Cell Biochem., 95, 1135–1145.
Kuan, C.Y., Whitmarsh, A.J., Yang, D.D., Liao, G., Schloemer, A.J., Dong, C.,
Bao, J., Banasiak, K.J., Haddad, G.G., Flavell, R.A., Davis, R.J. & Rakic, P.
(2003) A critical role of neural-specific JNK3 for ischemic apoptosis. Proc.
Natl Acad. Sci. USA, 100, 15184–15189.
Minogue, A.M., Schmid, A.W., Fogarty, M.P., Moore, A.C., Campbell, V.A.,
Herron, C.E. & Lynch, M.A. (2003) Activation of the c-Jun N-terminal
kinase signaling cascade mediates the effect of amyloid-beta on long term
potentiation and cell death in hippocampus: a role for interleukin-1beta?
J. Biol. Chem., 278, 27971–27980.
Nicoll, R.A., Oliet, S.H. & Malenka, R.C. (1998) NMDA receptor-dependent
and metabotropic glutamate receptor-dependent forms of long-term depression coexist in CA1 hippocampal pyramidal cells. Neurobiol. Learn. Mem.,
70, 62–72.
Nosyreva, E.D. & Huber, K.M. (2005) Developmental switch in synaptic
mechanisms of hippocampal metabotropic glutamate receptor-dependent
long-term depression. J. Neurosci., 25, 2992–3001.
Oliet, S.H., Malenka, R.C. & Nicoll, R.A. (1997) Two distinct forms of longterm depression coexist in CA1 hippocampal pyramidal cells. Neuron, 18,
969–982.
Resnick, L. & Fennell, M. (2004) Targeting JNK3 for the treatment of
neurodegenerative disorders. Drug Discov. Today, 9, 932–939.
Sabapathy, K., Hu, Y., Kallunki, T., Schreiber, M., David, J.P., Jochum, W.,
Wagner, E.F. & Karin, M. (1999a) JNK2 is required for efficient T-cell
activation and apoptosis but not for normal lymphocyte development. Curr.
Biol., 9, 116–125.
Vereker, E., O'Donnell, E. & Lynch, M.A. (2000) The inhibitory effect of
interleukin-1beta on long-term potentiation is coupled with increased
activity of stress-activated protein kinases. J. Neurosci., 20, 6811–6819.
Walz, R., Roesler, R., Barros, D.M., de Souza, M.M., Rodrigues, C.,
Sant'Anna, M.K., Quevedo, J., Choi, H.K., Neto, W.P., DeDavid e Silva,
T.L., Medina, J.H. & Izquierdo, I. (1999) Effects of post-training infusions of
a mitogen-activated protein kinase kinase inhibitor into the hippocampus or
entorhinal cortex on short- and long-term retention of inhibitory avoidance.
Behav. Pharmacol., 10, 723–730.
Wang, W., Shi, L., Xie, Y., Ma, C., Li, W., Su, X., Huang, S., Chen, R., Zhu, Z.,
Mao, Z., Han, Y. & Li, M. (2004b) SP600125, a new JNK inhibitor, protects
dopaminergic neurons in the MPTP model of Parkinson's disease. Neurosci.
Res., 48, 195–202.
Wang, Q., Walsh, D.M., Rowan, M.J., Selkoe, D.J. & Anwyl, R. (2004a) Block
of long-term potentiation by naturally secreted and synthetic amyloid betapeptide in hippocampal slices is mediated via activation of the kinases c-Jun
N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated
protein kinase as well as metabotropic glutamate receptor type 5.
J. Neurosci., 24, 3370–3378.
Zho, W.M., You, J.L., Huang, C.C. & Hsu, K.S. (2002) The group I
metabotropic glutamate receptor agonist (S)-3,5-dihydroxyphenylglycine
induces a novel form of depotentiation in the CA1 region of the
hippocampus. J. Neurosci., 22, 8838–8849.
